SCHEMBL7229129

SCHEMBL7229129

O=C(c1cc(-c2ccc(F)cc2)nc2ccccc12)N1CC[C@H](O)C1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.64
ALDH1A1 P00352 3/20 0.56
TSHR P16473 2/20 0.56
LMNA P02545 1/20 0.56
CYP2C9 P11712 3/20 0.56
TRPV1 Q8NER1 4/20 0.55
POLB P06746 2/20 0.54
HPGD P15428 2/20 0.54
USP2 O75604 1/20 0.54
TP53 P04637 1/20 0.54
HSD17B10 Q99714 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
GAA P10253 1/20 0.54
MAPK1 P28482 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 1/20 0.53
MOK Q9UQ07 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7229740 1.00 KDM4E (0.64) KDM4EALDH1A1TSHRLMNACYP2C9
SCHEMBL6163959 1.00 KDM4E (0.64) KDM4EALDH1A1TSHRLMNACYP2C9
SCHEMBL6163364 0.84 CYP2C9 (0.74) KDM4EALDH1A1TSHRLMNACYP2C9
SCHEMBL17434243 0.80 SMN1; SMN2 (0.61) KDM4EALDH1A1TSHRLMNACYP2C9
SCHEMBL17434236 0.80 ALOX5AP (0.49) ALDH1A1TSHRLMNACYP2C9TRPV1
SCHEMBL17434244 0.80 SMN1; SMN2 (0.61) KDM4EALDH1A1TSHRLMNACYP2C9
SCHEMBL17434234 0.80 ALOX5AP (0.49) ALDH1A1TSHRLMNACYP2C9TRPV1
SCHEMBL6163206 0.76 KDM4E (0.59) KDM4EALDH1A1TSHRLMNACYP2C9
SCHEMBL6161778 0.76 KDM4E (0.59) KDM4EALDH1A1TSHRLMNACYP2C9
SCHEMBL6161828 0.76 KDM4E (0.59) KDM4EALDH1A1TSHRLMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559163-B2 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression NEUROGEN CORPORATION 2003-05-06 US disclosed